Filtros de búsqueda

Lista de obras de Silvia Nozza

A case of HIV-associated fever of unknown origin: deficit of IL-1β antagonistic activity and resolution with monocyte–granulocyte apheresis

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses

artículo científico publicado en 2011

Ageing with HIV: a multidisciplinary review.

artículo científico

Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study

artículo científico publicado en 2014

B-cell subset alterations and correlated factors in HIV-1 infection

artículo científico publicado en 2013

Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets

artículo científico publicado en 2015

Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescent

artículo científico publicado en 2014

Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients

artículo científico publicado en 2011

Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: maraviroc, raltegravir, etravirine

artículo científico publicado en 2011

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting

artículo científico publicado en 2014

Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial.

artículo científico publicado en 2015

Dysfunctions in the migratory phenotype and properties of circulating immature transitional B cells during HIV-1 infection

artículo científico publicado en 2016

Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy

artículo científico publicado en 2015

Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.

artículo científico publicado en 2001

Erratum to: Ageing with HIV: a multidisciplinary review.

artículo científico publicado en 2015

Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis

article

Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir

artículo científico publicado en 2016

Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients.

artículo científico publicado en 2014

Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption

artículo científico publicado en 2010

Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1.

artículo científico publicado en 2007

Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.

artículo científico publicado en 2014

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group

artículo científico publicado en 2013

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients.

artículo científico publicado en 2014

HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients

artículo científico publicado en 2018

Identification and experimental validation of an HIV model for HAART treated patients.

artículo científico publicado en 2013

Immortal time bias: authors' reply

artículo científico publicado en 2015

Immune recovery and T cell subset analysis during effective treatment with maraviroc

artículo científico publicado en 2012

Immunological recovery after 24 weeks of antiretroviral therapy in patients with X4 virus during primary HIV infection

artículo científico publicado en 2014

Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration

article

Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals

artículo científico publicado en 2011

Is statin preventing cancer in HIV-1 infected individuals? An inappropriate methodology is a more likely explanation: authors' reply

artículo científico publicado en 2015

Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2

article

Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology

artículo científico

Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients

artículo científico publicado en 2012

Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens

artículo científico publicado en 2012

Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study

artículo científico publicado en 2014

Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up

artículo científico publicado en 2016

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism

artículo científico publicado en 2010

Monkeypox and pan-resistant Campylobacter spp infection in Entamoeba histolytica and Chlamydia trachomatis re-infection in a man who have sex with men

scientific article published on 03 July 2022

Monotherapy With Atazanavir as a Simplificati Strategy

Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretrovirals

artículo científico publicado en 2004

Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment

artículo científico publicado en 2016

Oral CCR5 inhibitors: will they make it through?

artículo científico publicado en 2006

Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients

artículo científico publicado en 2015

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group

artículo científico publicado en 2010

Persistence of CCR5 usage among primary human immunodeficiency virus isolates of individuals receiving intermittent interleukin-2.

artículo científico publicado en 2009

Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients

artículo científico publicado en 2013

Pharmacokinetics of the raltegravir/maraviroc/etravirine combination

scientific article published on 04 June 2011

Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort

artículo científico publicado en 2017

Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient

artículo científico publicado en 2013

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience

artículo científico publicado en 2010

Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients

artículo científico publicado en 2014

Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results

artículo científico publicado en 2014

Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART.

artículo científico publicado en 2016

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study.

artículo científico publicado en 2018

The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection

article

The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT.

artículo científico publicado en 2008

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

artículo científico publicado en 2014

Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2.

artículo científico publicado en 2002

Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy

artículo científico publicado en 2014

Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection

artículo científico publicado en 2014

Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts

artículo científico